The Changing Drug Culture

Emerging Drugs of Abuse and Legal Highs

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

In recent years, there has been a large increase in the number of synthetic drugs used recreationally. One class of drugs is synthetic cannabinoids, which are sprayed onto herbal preparations and marketed under names such as K2 and spice. Others include amphetaminelike compounds, such as cathinones (eg, bath salts) and methylenedioxymethamphetamine (MDMA) (eg, ecstasy, Molly). New hallucinogens, such as Bromo-Dragonfly, and hallucinogens that have been used for centuries, such as Salvia divinorum, also are gaining popularity. Because these substances are sold labeled as not for human consumption and because the chemicals in them frequently change, they often are unregulated, and many users consider them legal, although they are not. Their use often goes undetected because testing for them is not included in routine drug screening. Nonetheless, these substances can be associated with significant toxicities, often because their concentrations are unpredictable. Adverse effects of synthetic cannabinoids include psychosis and other effects. Amphetaminelike drugs have stimulant effects and can cause hyponatremia and seizures. The new hallucinogens can cause serious vasoconstriction with ischemia. Clinicians, especially those working with adolescents and young adults (ie, the main users of these drugs), should be aware of these new substances and counsel patients about their adverse effects.

Original languageEnglish (US)
Pages (from-to)18-24
Number of pages7
JournalFP essentials
Volume441
StatePublished - Feb 1 2016

Fingerprint

Hallucinogens
Street Drugs
Cannabinoids
Odonata
Pharmaceutical Preparations
Poecilia
Salvia
Plant Preparations
N-Methyl-3,4-methylenedioxyamphetamine
Spices
Preclinical Drug Evaluations
Hyponatremia
Drug Users
Vasoconstriction
Baths
Psychotic Disorders
Names
Young Adult
Seizures
Ischemia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The Changing Drug Culture : Emerging Drugs of Abuse and Legal Highs. / Albertson, Timothy E; Chenoweth, James; Colby, Daniel; Sutter, Mark E.

In: FP essentials, Vol. 441, 01.02.2016, p. 18-24.

Research output: Contribution to journalReview article

@article{c5829d8da1d84c68afa54675a0d63aa0,
title = "The Changing Drug Culture: Emerging Drugs of Abuse and Legal Highs",
abstract = "In recent years, there has been a large increase in the number of synthetic drugs used recreationally. One class of drugs is synthetic cannabinoids, which are sprayed onto herbal preparations and marketed under names such as K2 and spice. Others include amphetaminelike compounds, such as cathinones (eg, bath salts) and methylenedioxymethamphetamine (MDMA) (eg, ecstasy, Molly). New hallucinogens, such as Bromo-Dragonfly, and hallucinogens that have been used for centuries, such as Salvia divinorum, also are gaining popularity. Because these substances are sold labeled as not for human consumption and because the chemicals in them frequently change, they often are unregulated, and many users consider them legal, although they are not. Their use often goes undetected because testing for them is not included in routine drug screening. Nonetheless, these substances can be associated with significant toxicities, often because their concentrations are unpredictable. Adverse effects of synthetic cannabinoids include psychosis and other effects. Amphetaminelike drugs have stimulant effects and can cause hyponatremia and seizures. The new hallucinogens can cause serious vasoconstriction with ischemia. Clinicians, especially those working with adolescents and young adults (ie, the main users of these drugs), should be aware of these new substances and counsel patients about their adverse effects.",
author = "Albertson, {Timothy E} and James Chenoweth and Daniel Colby and Sutter, {Mark E}",
year = "2016",
month = "2",
day = "1",
language = "English (US)",
volume = "441",
pages = "18--24",
journal = "FP essentials",
issn = "2159-3000",
publisher = "American Academy of Family Physicians",

}

TY - JOUR

T1 - The Changing Drug Culture

T2 - Emerging Drugs of Abuse and Legal Highs

AU - Albertson, Timothy E

AU - Chenoweth, James

AU - Colby, Daniel

AU - Sutter, Mark E

PY - 2016/2/1

Y1 - 2016/2/1

N2 - In recent years, there has been a large increase in the number of synthetic drugs used recreationally. One class of drugs is synthetic cannabinoids, which are sprayed onto herbal preparations and marketed under names such as K2 and spice. Others include amphetaminelike compounds, such as cathinones (eg, bath salts) and methylenedioxymethamphetamine (MDMA) (eg, ecstasy, Molly). New hallucinogens, such as Bromo-Dragonfly, and hallucinogens that have been used for centuries, such as Salvia divinorum, also are gaining popularity. Because these substances are sold labeled as not for human consumption and because the chemicals in them frequently change, they often are unregulated, and many users consider them legal, although they are not. Their use often goes undetected because testing for them is not included in routine drug screening. Nonetheless, these substances can be associated with significant toxicities, often because their concentrations are unpredictable. Adverse effects of synthetic cannabinoids include psychosis and other effects. Amphetaminelike drugs have stimulant effects and can cause hyponatremia and seizures. The new hallucinogens can cause serious vasoconstriction with ischemia. Clinicians, especially those working with adolescents and young adults (ie, the main users of these drugs), should be aware of these new substances and counsel patients about their adverse effects.

AB - In recent years, there has been a large increase in the number of synthetic drugs used recreationally. One class of drugs is synthetic cannabinoids, which are sprayed onto herbal preparations and marketed under names such as K2 and spice. Others include amphetaminelike compounds, such as cathinones (eg, bath salts) and methylenedioxymethamphetamine (MDMA) (eg, ecstasy, Molly). New hallucinogens, such as Bromo-Dragonfly, and hallucinogens that have been used for centuries, such as Salvia divinorum, also are gaining popularity. Because these substances are sold labeled as not for human consumption and because the chemicals in them frequently change, they often are unregulated, and many users consider them legal, although they are not. Their use often goes undetected because testing for them is not included in routine drug screening. Nonetheless, these substances can be associated with significant toxicities, often because their concentrations are unpredictable. Adverse effects of synthetic cannabinoids include psychosis and other effects. Amphetaminelike drugs have stimulant effects and can cause hyponatremia and seizures. The new hallucinogens can cause serious vasoconstriction with ischemia. Clinicians, especially those working with adolescents and young adults (ie, the main users of these drugs), should be aware of these new substances and counsel patients about their adverse effects.

UR - http://www.scopus.com/inward/record.url?scp=84975256762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975256762&partnerID=8YFLogxK

M3 - Review article

VL - 441

SP - 18

EP - 24

JO - FP essentials

JF - FP essentials

SN - 2159-3000

ER -